Viela Bio

Developer of biologics for treating severe inflammation and autoimmune diseases

placeGaithersburg, Maryland, United States calendar_todayFounded 2017 groups170 employees language vielabio.com

Registered entities

Innovation

27 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 1,392 times.

YearFilings
20131
20172
20183
20193
20206
20218
202214
202319
202418
202512
20264

Investor mix

12 investors on record; lead investors include HBM Healthcare Investments, 6 Dimensions Capital, Boyu Capital, Hillhouse; 3 have since exited.

Investor typeCountShare
Venture capital433%
Private equity433%
Bank & private debt18%
Other / undisclosed325%
Coming soon